###begin article-title 0
###xml 138 142 <span type="species:ncbi:10090">mice</span>
Selective reconstitution of liver cholesterol biosynthesis promotes lung maturation but does not prevent neonatal lethality in Dhcr7 null mice
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 77 82 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 27 33 <span type="species:ncbi:10090">murine</span>
Targeted disruption of the murine 3beta-hydroxysterol-Delta7-reductase gene (Dhcr7), an animal model of Smith-Lemli-Opitz syndrome, leads to loss of cholesterol synthesis and neonatal death that can be partially rescued by transgenic replacement of DHCR7 expression in brain during embryogenesis. To gain further insight into the role of non-brain tissue cholesterol deficiency in the pathophysiology, we tested whether the lethal phenotype could be abrogated by selective transgenic complementation with DHCR7 expression in the liver.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DHCR7 </italic>
###xml 222 231 222 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7+/- </italic>
###xml 251 260 251 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7-/- </italic>
###xml 281 287 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DHCR7 </italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 275 280 <span type="species:ncbi:9606">human</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
We generated mice that carried a liver-specific human DHCR7 transgene whose expression was driven by the human apolipoprotein E (ApoE) promoter and its associated liver-specific enhancer. These mice were then crossed with Dhcr7+/- mutants to generate Dhcr7-/- mice bearing a human DHCR7 transgene. Robust hepatic transgene expression resulted in significant improvement of cholesterol homeostasis with cholesterol concentrations increasing to 80~90 % of normal levels in liver and lung. Significantly, cholesterol deficiency in brain was not altered. Although late gestational lung sacculation defect reported previously was significantly improved, there was no parallel increase in postnatal survival in the transgenic mutant mice.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 343 347 343 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
The reconstitution of DHCR7 function selectively in liver induced a significant improvement of cholesterol homeostasis in non-brain tissues, but failed to rescue the neonatal lethality of Dhcr7 null mice. These results provided further evidence that CNS defects caused by Dhcr7 null likely play a major role in the lethal pathogenesis of Dhcr7-/- mice, with the peripheral organs contributing the morbidity.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 514 519 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DHCR7</italic>
###xml 522 523 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 524 526 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 541 547 534 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7 </italic>
###xml 121 126 <span type="species:ncbi:9606">human</span>
###xml 561 566 <span type="species:ncbi:10090">mouse</span>
###xml 919 924 <span type="species:ncbi:9606">human</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
The role of cholesterol in embryonic development is an important question in biology, with significant ramifications for human disease [1,2]. Defects in post-squalene cholesterol biosynthesis, such as in Smith-Lemli-Opitz syndrome (SLOS, MIM 270400) or desmosterolosis (MIM 603398), disrupt the synthesis of cholesterol and cause a variety of severe developmental abnormalities [3-8]. SLOS is a complex inborn error of cholesterol biosynthesis caused by mutations of the 3beta-hydroxysterol-Delta7 reductase gene (DHCR7) [9-11]. The lack of Dhcr7 expression in mouse mimics the early postnatal lethality observed in severely affected individuals (those with the condition formerly referred to as SLOS type II). The biological changes in development caused by disruption of normal cholesterol biosynthesis that result in this early postnatal lethality remain obscure. As a genetic model for understanding of the SLOS in human, mice lacking Dhcr7 provide a useful model to determine which affected tissues are critically responsible for the lethality and which ones may contribute to the morbidity.
###end p 9
###begin p 10
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 551 556 551 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 556 560 556 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1189 1194 1189 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1194 1198 1194 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1384 1386 1384 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 361 366 <span type="species:ncbi:10090">mouse</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 1063 1068 <span type="species:ncbi:9606">human</span>
###xml 1069 1077 <span type="species:ncbi:9606">patients</span>
###xml 1198 1202 <span type="species:ncbi:10090">mice</span>
One cause of early postnatal death in the Dhcr7 null animals appears to be associated with anoxia due to diffuse atelectasis of the late gestational lungs [12-14], which may cause immature formation of gas-exchange unit and subsequent respiratory insufficiency after birth [2,14]. Therefore, lung involvement seems to be a cause of neonatal death in Dhcr7 null mouse model. However, there is still uncertainty regarding the mechanism(s) responsible for the late gestational lung hypoplasia caused by the loss of endogenous cholesterol biosynthesis in Dhcr7-/- mice. As with any biological aspect of a generalized cholesterol deficiency, the pathophysiology is likely to be complex and multi-factorial. It remains unclear whether the delayed lung maturation is caused by a developmental defect intrinsic to lung or whether it represents a systemic abnormality, especially of the central nervous system (CNS), because of impaired cholesterol homeostasis during embryogenesis. A different variety of developmental abnormalities in brain have also been noted in both human patients and, to some extent, in Dhcr7-deficient animal models. In this regard, we have also recently demonstrated that Dhcr7-/- mice can be partially rescued from neonatal death by a low level restoration of DHCR7 expression in brain, indicating that neuropathophysiology is one cause of their neonatal lethality [15].
###end p 10
###begin p 11
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 917 922 917 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 922 926 922 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
In attempting to rescue Dhcr7-deficient mice, we felt that it was necessary to consider the liver because that organ is a major source of cholesterol for most developing organs, except for brain [4,16-19]. Thus, we hypothesized that restoration of normal cholesterol synthesis in the liver might be able to abrogate the lethality. In the current study, we asked whether the specific reconstitution of DHCR7 expression in liver would alleviate the cholesterol deficiency and afford protection from early postnatal death in Dhcr7 null mice. Our results suggest that, although expression of DHCR7 in liver alone during development induced a significant improvement in cholesterol homeostasis in non-brain tissues and promoted lung maturation, it failed to rescue the neonatal lethality. These results provided further evidence that CNS defects caused by Dhcr7 null likely play a major role in the lethal pathogenesis of Dhcr7-/- mice, with the peripheral organs contributing the morbidity.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Characterization of TgDHCR7 lines
###end title 13
###begin p 14
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A,C</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1116 1118 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 473 478 <span type="species:ncbi:9606">human</span>
###xml 844 850 <span type="species:ncbi:10090">murine</span>
Three mice (one female and two males), referred as to TgDHCR7-1, TgDHCR7-2 and TgDHCR7-3, respectively (Fig. 1), were identified as transgenic on the basis of PCR and Southern blot analyses of tail samples of genomic DNA. Multiple tissues were collected from N2 transgenic progeny from the founder mice crossed with C57Bl/6J at postnatal day (P) 10 and analyzed for transgene expression by RT-PCR and immunoblotting. Both TgDHCR7-2 and TgDHCR7-3 transgenic lines expressed human DHCR7 mRNA robustly in the postnatal livers, but not in the other tissues (Fig. 2A,C) and western blotting analyses showed expression of HA-tagged protein (Fig. 2D). TgDHCR7 mRNA transcript was detected in transgenic liver at E11.5 (the earliest we could dissect liver tissue) by RT-PCR determination (Fig. 2B) and was quantitatively ~5 fold higher than endogenous murine Dhcr7 mRNA in the transgenic liver at E16.5 as judged by real-time PCR (Fig. 2C). Immunofluorescence staining with anti-HA antibody showed that TgDHCR7 was highly expressed in hepatocytes in liver sections, but such signal was not detectable in control liver (Fig. 2E). Further studies therefore utilized these two lines, which were backcrossed with C57Bl/6J for 4 to 5 generations. Since no differences between either line were identified, these lines were used interchangeably.
###end p 14
###begin p 15
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 0 26 0 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Generation of <italic>TgDHCR7 </italic>mice</bold>
###xml 28 36 28 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A </bold>
###xml 366 374 366 374 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel B </bold>
###xml 425 429 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam </italic>
###xml 460 468 460 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 469 471 469 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 573 576 568 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg </italic>
###xml 653 661 648 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 245 250 <span type="species:ncbi:9606">human</span>
###xml 297 302 <span type="species:ncbi:9606">human</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
Generation of TgDHCR7 mice. Panel A shows a cartoon of the transgene construct used for microinjection. The human Apo E promoter containing non-coding exon 1 (E1), intron 1 and part of non-coding exon 2 (E2) was fused to a N-terminal 3HA tagged human DHCR7 cDNA containing intron 5, followed by a human Apo E poly A addition site (pA), and a liver enhancer element. Panel B shows the results of the Southern blot analysis of Bam HI-digested DNA from the three TgDHCR7 (Tg) founder mice (lane 3, 4 and 5). Lane 1 is lambda-Hind III DNA marker and lane 2 contains DNA from a Tg negative control animal. The arrowhead points to the expected size bands for TgDHCR7 (2.3 kb). Additional bands (asterisks) indicate the integrated transgene that has undergone some deletions or rearrangements.
###end p 15
###begin p 16
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Characterization of <italic>TgDHCR7 </italic>transgene expression</bold>
###xml 50 58 50 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A </bold>
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 289 297 289 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel B </bold>
###xml 318 326 318 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 530 538 530 538 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel C </bold>
###xml 587 594 587 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7</italic>
###xml 626 636 626 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">endo-Dhcr7</italic>
###xml 740 746 740 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7 </italic>
###xml 787 796 785 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg-DHCR7 </italic>
###xml 811 817 809 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7 </italic>
###xml 837 845 835 843 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel D </bold>
###xml 929 937 927 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 938 940 936 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 959 962 957 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg </italic>
###xml 1051 1061 1049 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7-2 </italic>
###xml 1065 1075 1063 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7-3 </italic>
###xml 1154 1157 1152 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg </italic>
###xml 1624 1632 1622 1630 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel E </bold>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
###xml 1174 1178 <span type="species:ncbi:10090">mice</span>
Characterization of TgDHCR7 transgene expression. Panel A shows the tissue distribution of TgDHCR7 transgene mRNA as determined by RT-PCR. Amplification was performed with primers bounding the intron in the transgene. Note that expression was readily detectable on the liver tissues only. Panel B shows the profile of TgDHCR7 transgene expression during embryonic liver development, determined by RT-PCR. The samples were taken from embryonic days as indicated. Robust expression was detectable in liver tissue as early as E11.5. Panel C shows quantitation of transgene mRNA expression (TgDHCR7) relative to endogenous Dhcr7 (endo-Dhcr7) in liver samples by real-time RT-PCR. The transgene message was almost 5-fold greater than endogenous Dhcr7 message. The mean +/- SD of Ct values of Tg-DHCR7 and endogenous Dhcr7 are shown in chart. Panel D shows protein expression of transgenic HA-tagged DHCR7 from the multiple tissues of TgDHCR7 (Tg) positive (+) and Tg negative (-) control mice. Membrane and cytosolic fractions from the multiple tissues of TgDHCR7-2 and TgDHCR7-3 positive animals (liver 1 and 2 respectively, lanes 3 and 4) and the livers of Tg negative control mice (liver 3 and 4, lanes 5 and 6) were prepared for immunoblotting analyses as described in Methods. The upper panel shows western blotting data using monoclonal anti-HA antibody (arrow denotes DHCR7 ~43 kDa). The asterisk at 48 KDa indicates immunoreactivity to IgG heavy chain in the samples. Middle and lower panels are immunoblots for calnexin (an ER membrane marker) and caveolin-1 (cav1, a plasma membrane marker), respectively, as controls. Panel E shows immunohistochemical staining with anti-HA antibody (left panel) and phase-contrast (middle panel) images of transgenic liver sections. No signal was detected with the antibody in control liver (right panel). T indicates liver portal triad.
###end p 16
###begin title 17
###xml 41 45 41 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Sterol metabolic profile of TgDHCR7/Dhcr7-/- mice
###end title 17
###begin p 18
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 384 387 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 387 389 387 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
To determine the physiological consequences of selective restoration of DHCR7 expression in liver, we bred the transgene onto Dhcr7 null background (see Methods). Steady-state sterol levels in P0-P1 neonates were obtained by sacrificing the litters from the initial crosses, tissues and plasma harvested and genotypes performed on DNA extracted from tails. Cholesterol levels in Dhcr7-/-Tg+ plasma (pooled plasma from 9 animals, pooling performed by combining plasma from 3 pups) were significantly improved compared to non-transgenic Dhcr7-null plasma (Fig. 3A), plasma 7-dehydrocholesterol (7DHC) and 8-dehydrocholesterol (8DHC) sterols were reduced and the percentage precursor levels significantly decreased (cf. Fig. 3B and 3C). Thus the expression of the transgene in the liver led to improvements in the plasma sterol profiles.
###end p 18
###begin p 19
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pooled plasma sterol analyses from neonatal pups</bold>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 245 248 245 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 248 250 248 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 261 264 261 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 264 266 264 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 343 350 337 344 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A</bold>
###xml 449 454 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 454 457 446 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 457 459 449 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 493 498 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 498 501 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 501 503 491 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 539 544 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 544 547 532 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 547 549 535 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 599 606 587 594 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel B</bold>
###xml 681 686 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 686 689 674 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 689 691 677 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 730 735 716 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 735 738 721 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 738 740 724 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 766 773 750 757 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel C</bold>
###xml 805 807 789 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 809 814 793 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 814 817 798 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 817 819 801 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 825 830 809 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 830 833 814 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 833 835 817 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
Pooled plasma sterol analyses from neonatal pups. Sterol levels in three pooled plasma samples (9 pups per genotype, pooled by combining samples from 3 pups) collected from animals of each genotype. Plasma cholesterol levels (mg/dl) in WT, Dhcr7-/-Tg- and Dhcr7-/-Tg+ neonates were 71.7 +/- 5.68, 13.5 +/- 1.3 and 33.7 +/- 10.4, respectively (Panel A). 7/8DHC (mg/dl) was 0.12 +/- 0.04 in WT plasma and a massive accumulation of 7/8DHC was found in Dhcr7-/-Tg- (10.5 +/- 1.8). 7/8DHC level in Dhcr7-/-Tg+ plasma (5.7 +/- 0.7) was ~50 % of Dhcr7-/-Tg- level, but still ~47-fold higher than WT level (Panel B). The percent of sterol precursors appeared to be dramatically reduced in Dhcr7-/-Tg+ plasma (19.5 +/- 7.6 %), compared to Dhcr7-/-Tg- mice (77.6 +/- 13.6 %) (Panel C). And total sterols (mg/dl) in WT, Dhcr7-/-Tg- and Dhcr7-/-Tg+ neonates were 71.8 +/- 5.67, 23.9 +/- 2.62 and 39.3 +/- 10.1, respectively. Results are expressed as mean +/- SD.
###end p 19
###begin p 20
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 33 35 33 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 299 304 <span type="species:ncbi:10090">mouse</span>
Liver sterol profiles in Dhcr7-/-Tg+ pups showed that tissue cholesterol was restored to almost wild-type liver level and precursor levels were reduced by ~70% suggesting the liver defect was not fully restored (Fig. 4). It is important to note that whole liver tissue in the embryonic and neonatal mouse also contains substantial non-hepatic (primarily hematopoetic) cells.
###end p 20
###begin p 21
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sterol analyses of liver tissues from wild-type, knockout and knockout- transgenic pups</bold>
###xml 89 97 89 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A </bold>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 158 160 158 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 208 211 206 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cf </italic>
###xml 410 415 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 415 418 409 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 418 420 412 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 526 531 518 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 531 534 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 534 536 526 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 575 582 565 572 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel B</bold>
###xml 645 650 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 650 653 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 653 655 641 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 835 840 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 840 843 826 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 843 845 829 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 881 886 865 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 886 889 870 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 889 891 873 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 923 930 905 912 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel C</bold>
###xml 1078 1083 1056 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1083 1086 1061 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1086 1088 1064 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 1110 1115 1086 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1115 1118 1091 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1118 1120 1094 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
Sterol analyses of liver tissues from wild-type, knockout and knockout- transgenic pups. Panel A shows that the significant cholesterol deficiency in Dhcr7-/-Tg- neonates (1.0 +/- 0.53 mg/g tissue, P < 0.001 cf to WT) was restored to normal by the transgene expression (2.03 +/- 0.64 mg/g tissue) and was not statistically different from WT livers (2.48 +/- 0.38 mg/g tissue). Cholesterol level in livers from Dhcr7+/+Tg+ littermates was 2.45 +/- 0.42 mg/g tissue (data not shown). Massive accumulation of 7/8DHC in livers of Dhcr7-/-Tg- neonates (1.46 +/- 0.45 mg/g tissue, Panel B), was significantly decreased to 0.48 +/- 0.33 mg/g tissue in Dhcr7-/-Tg+ livers and only trace levels in livers of WT mice were detected (0.01 +/- 0.02 mg/g tissue). The percent of sterol precursors in total sterols was also significantly improved in Dhcr7-/-Tg+ livers (19 +/- 13 %), compared to Dhcr7-/-Tg- mice (59 +/- 12 %, p < 0.001, Panel C). No significant difference (p > 0.05) was found in total sterol levels (mg/g tissue) among the three groups (2.49 +/- 0.49 in WT, 2.43 +/- 0.53in Dhcr7-/-Tg- and 2.51 +/- 0.51in Dhcr7-/-Tg+). Results are expressed as mean +/- SD.
###end p 21
###begin p 22
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 44 46 44 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 475 480 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 480 483 480 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 483 485 483 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 874 879 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 879 882 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 882 884 882 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
Remarkably, tissue sterol levels in Dhcr7-/-Tg+ lung also showed a dramatic restoration of cholesterol (Fig. 5A). Precursor sterol profiles were also significantly improved, and were similar in profile to that observed for the liver (Fig. 5B and 5C), though the reductions were more modest (~40%). In contrast, there was almost no change in the sterol profiles in brain from knockout animals that expressed the transgene in the liver (Fig. 6). Although cholesterol levels in Dhcr7-/-Tg+ brains were statistically higher than non-transgenic mutant brains (Fig 6A), this increase was minimal and the brains showed significant cholesterol deficiency. Additionally, the presence of the transgene had no effect on either the total 7/8DHC precursors (Fig. 6B) or the different species of precursors (Fig. 6C). We speculate that the small increase in brain cholesterol seen in the Dhcr7-/-Tg+ may reflect the contamination of the brain by the increased cholesterol in the blood.
###end p 22
###begin p 23
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sterol analyses of lung tissues from wild-type, knockout and knockout- transgenic pups</bold>
###xml 88 96 88 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A </bold>
###xml 232 237 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 237 240 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 240 242 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 472 477 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 477 480 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 480 482 474 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 544 552 536 544 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel B </bold>
###xml 638 643 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 643 646 633 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 646 648 636 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 650 653 640 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cf </italic>
###xml 682 687 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 687 690 675 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 690 692 678 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 843 848 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 848 851 832 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 851 853 835 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 872 879 856 863 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel C</bold>
###xml 1040 1045 1020 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1045 1048 1025 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1048 1050 1028 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 1073 1078 1051 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1078 1081 1056 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1081 1083 1059 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 855 859 <span type="species:ncbi:10090">mice</span>
Sterol analyses of lung tissues from wild-type, knockout and knockout- transgenic pups. Panel A shows that cholesterol level in lung tissues was restored to normal by the liver transgene expression (to 2.51 +/- 0.71 mg/g tissue) in Dhcr7-/-Tg+ lungs and was not statistically different from WT lungs (of 3.06 +/- 0.40 mg/g tissue), while the non-transgenic-KO lungs exhibited significant cholesterol deficiency (1.25 +/- 0.44 mg/g tissue). Cholesterol level in lungs from Dhcr7+/+Tg+ littermates was 3.18 +/- 0.54 mg/g tissue (data not shown). Panel B shows that this also led to a fall in precursor sterols (0.88 +/- 0.30 mg/g tissue in Dhcr7-/-Tg+ cf 1.39 +/- 0.22 mg/g tissue in Dhcr7-/-Tg-), with a significant fall in the percentage of precursor sterol in the lung tissues of the transgenic-KO mice (25 +/- 8 %, compared to 53 +/- 5 % in Dhcr7-/-Tg- mice, p < 0.001, Panel C). There was no significant difference (p > 0.05) in total sterols among the three groups (lung total sterols mg/g tissue: 3.10 +/- 0.40 in WT, 2.64 +/- 0.62 in Dhcr7-/-Tg- and 3.59 +/- 1.08 in Dhcr7-/-Tg+, data not shown). Error bars represent mean +/- SD.
###end p 23
###begin p 24
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sterol analyses in brain tissues from wild-type, knockout and knockout- transgenic pups</bold>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 145 148 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 148 150 148 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 177 180 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 180 182 180 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 227 232 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 232 235 230 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 235 237 233 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 278 283 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 283 286 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 286 288 282 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 327 334 323 330 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A</bold>
###xml 431 436 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 436 439 430 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 439 441 433 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 476 481 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 481 484 473 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 484 486 476 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 500 507 492 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel B</bold>
###xml 554 559 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 559 562 551 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 562 566 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 592 597 582 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 597 600 587 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 600 602 590 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 635 642 623 630 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel C</bold>
###xml 792 797 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 797 800 781 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 800 802 784 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 825 830 807 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 830 833 812 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 833 835 815 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
Sterol analyses in brain tissues from wild-type, knockout and knockout- transgenic pups. A slightly elevated cholesterol level was found in Dhcr7-/-Tg+ brains, compared to Dhcr7-/-Tg- brains (0.58 +/- 0.03 mg/g brain tissue in Dhcr7-/-Tg+ vs. 0.47 +/- 0.06 mg/g brain tissue in Dhcr7-/-Tg-, p < 0.05, see Text for discussion) (Panel A). However, there were no significant alterations of 7/8DHC levels (3.42 +/- 0.53 mg/g tissue in Dhcr7-/-Tg+ vs. 3.01 +/- 0.38 mg/g tissue in Dhcr7-/-Tg-, p > 0.05) (Panel B), or of the ratios of different precursors in Dhcr7-/-Tg+ (89 +/- 1 %), compared to Dhcr7-/-Tg- brains (91 +/- 2 %, p > 0.05) (Panel C). No significant difference (p > 0.05) was found in brain total sterol levels among three groups (mg/g tissue: 4.63 +/- 0.46 in WT, 5.05 +/- 0.68 in Dhcr7-/-Tg- and 5.33 +/- 0.66 in Dhcr7-/-Tg+, data not shown). Results are expressed as mean +/- SD.
###end p 24
###begin p 25
Collectively, these data indicated that selective reconstitution of DHCR7 expression in liver improved significantly cholesterol homeostasis in liver, lung and circulation of Dhcr7 null animals during embryogenesis, but did not affect metabolism in the brain.
###end p 25
###begin title 26
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Late gestational lung development in Dhcr7-/-Tg+ mice
###end title 26
###begin p 27
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 562 569 562 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, Dhcr7</italic>
###xml 569 572 569 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 572 574 572 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 585 588 585 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 588 590 588 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7F</xref>
###xml 1132 1134 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 1139 1141 1139 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 1296 1298 1296 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7G</xref>
###xml 1399 1400 1399 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 1639 1640 1635 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
Loss of Dhcr7 in mice leads to subtle, but reproducible defects in lung development; all knockout pups show impaired saccular and capillary growth development caused by developmental arrest at the very last stages of lung development [14]. The primary cell defect seems to be a failure of terminal differentiation of type 1 alveolar epithelial cells (AECs). Since the hepatic transgene expression led to an increase in significant amounts of lung tissue cholesterol, we examined for effects on lung phenotype in near term embryos (E19.5) that were wild-type (WT), Dhcr7-/-Tg+ and Dhcr7-/-Tg-. At this stage, the lungs of WT mice showed normal sacculation (Fig. 7A) with formation of pre-alveoli that have thin septa (Fig. 7B). In contrast, lungs from Dhcr7 null mice (Fig. 7E and 7F) showed the lack of saccular formation, with failure to thin out the pre-alveolar septae and development of sac spaces, in keeping with our previous findings. Interestingly, the lungs from Dhcr7 null mice expressing DHCR7 in the liver showed an intermediate phenotype, with improved sac space formation and thinning of the pre-alveolar septae (Fig. 7C and 7D). Analyses of the sac space volumes showed that transgenic KO lungs had an increase in terminal sac spaces, compared to non-transgenic mutant lungs (Fig. 7G). Immunohistochemical characterization of these lungs confirmed this histological improvement (Fig. 8). We had previously shown abnormal T1-alpha, PECAM-1 and caveolin-1 staining patterns in Dhcr7 null lungs, with preserved surfactant protein staining. The transgene expression led to an improvement in all of these staining patterns (Fig. 8, cf. panels B, E, H and K with C, F, I and L), suggesting that transgenic-induced improvement of cholesterol homeostasis in non-brain tissues normalized the architecture of the distal lung sacculation.
###end p 27
###begin p 28
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lung histology in wild-type, knockout and knockout-transgenic embryos</bold>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 116 119 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 274 288 274 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panels A and B</bold>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 419 422 419 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 633 647 633 647 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panels E and F</bold>
###xml 783 787 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 800 814 800 814 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panels C and D</bold>
###xml 866 871 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 871 874 871 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 874 878 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 887 895 887 895 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel G </bold>
###xml 971 976 971 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 976 979 976 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 979 983 979 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 987 992 987 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 992 995 992 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 995 999 995 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
Lung histology in wild-type, knockout and knockout-transgenic embryos. Histological sections of lungs from WT, Dhcr7-/-Tg+ and Dhcr7-/-Tg- at term (E19.5) were stained with hematoxylin/eosin (H & E) and photographed. WT lung depicts late saccular phase of lung development (Panels A and B). Considerable elongation of the secondary crests (arrows) and a more thinned mesenchyme are evident throughout the WT lung. Dhcr7-/-Tg- lung showed less distal saccular structures, had thick-walled mesenchyme and septation appeared not to be progressing, with undeveloped epithelial tubular structures (arrowheads) throughout the lung fields (Panels E and F). Although these changes are also present in the lungs from transgenic-KO lungs, less severe hypoplasic lung phenotypes are evident in Tg+ mutant mice (Panels C and D, arrows show secondary crests), compared to WT and Dhcr7-/-Tg- animals. Panel G shows the morphometric analyses of lung terminal sac spaces in lungs of WT, Dhcr7-/-Tg+ and Dhcr7-/-Tg- at E19.5. Results are expressed as mean +/- SD. Labels: a, pre-alveolar spaces; br, bronchiole.
###end p 28
###begin p 29
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunostaining of selected marker proteins expressed in distal lung</bold>
###xml 109 129 109 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panels A, D, G and J</bold>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 145 165 145 165 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panels B, E, H and K</bold>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 176 179 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 184 204 184 204 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panels C, F, I and L</bold>
###xml 461 466 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 466 469 462 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 469 473 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 487 492 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 492 495 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 495 499 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 753 758 741 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 758 761 746 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 761 765 749 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 972 977 960 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 977 980 965 968 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 980 984 968 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 1067 1072 1051 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1072 1075 1056 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1075 1079 1059 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 1154 1159 1138 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1159 1162 1143 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1162 1166 1146 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
Immunostaining of selected marker proteins expressed in distal lung. Lung sections at E19.5 from WT control (Panels A, D, G and J), Dhcr7-/-Tg+ (Panels B, E, H and K) and Dhcr7-/-Tg- (Panels C, F, I and L) were immunostained with antibodies against T1-alpha, SP-C, caveolin-1 (cav-1), and PECAM-1, respectively. Immunostaining for SP-C shows relative similar patterns and numbers of positive cells (brown dots, indicated by arrowheads) in WT control (Panel D), Dhcr7-/-Tg+ (Panel E) and Dhcr7-/-Tg- (Panel F) lungs. T1-alpha expression in WT lung (Panel A) is confined to flattened cells lining the pre-alveolar spaces (arrow). A decreased pattern of T1-alpha expression, especially in undeveloped epithelial tubules (arrowheads), is clearly evident in Dhcr7-/-Tg- lung (Panel C). Both cav-1 (Panel G) and PECAM-1 (Panel J) staining demonstrate an extensive vascular network in the well developed saccules in WT lung, however, delayed vascular development was observed in Dhcr7-/-Tg- lung (Panel I and L). Note that T1-alpha, cav-1 and PECAM-1 expressive patterns in Dhcr7-/-Tg+ lung (Panels B, H and K, respectively) appear in the middle between WT and Dhcr7-/-Tg- lungs. Labels: a, pre-alveolar spaces; br, bronchiole.
###end p 29
###begin title 30
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Postnatal survivability of Dhcr7-/-Tg+ mice
###end title 30
###begin p 31
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 227 230 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 230 232 230 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 257 260 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 260 262 260 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 398 399 398 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 624 629 624 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 629 632 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 705 710 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 710 713 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 713 715 713 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 930 935 930 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 935 938 935 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 938 940 938 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 1027 1032 1027 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1032 1035 1032 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1035 1037 1035 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
Since all of the Dhcr7 null pups die within 24 h of birth (usually within 14 h), we wished to see if the improvement in the cholesterol by liver transgene expression improved survival. One hundred and ninety-six pups from Dhcr7+/-Tg+ females bred with Dhcr7+/-Tg+ males were scored for viability. The survival rates, defined as pups remaining alive beyond 24 h after birth, are summarized in Table 1. When observed at birth, in general, pups that appeared bluish, hypotonic, breathed with difficulty, demonstrated no suckling activity, became dehydrated, and died within 24 h after birth were genotyped to be non-transgenic Dhcr7-/-, all features of being Dhcr7 null, as described previously [14]. Of the Dhcr7-/-Tg+ pups that were relatively pink within minutes after being born, twelve of 28 (42.8%) from TgDHCR7 line-2 and 8 of 14 (57.1%) from TgDHCR7 line-3 survived the first postnatal day, but died within 48 h after birth. Dhcr7-/-Tg+ pups were also observed to show some hypotonia and poor suckling reflexes similar to Dhcr7-/-Tg- pups. The remaining pups were sacrificed after 2 days to confirm that none of the survivors to this point were null for Dhcr7. Therefore, liver-specific restoration of cholesterol biosynthesis improved survival to up to 48 hours, but all Dhcr7 null pups still died. Thus, despite the hepatic, blood and non-brain tissue cholesterol and developmental improvements by hepatic transgene expression, lethality was minimally delayed.
###end p 31
###begin p 32
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7-</italic>
Survival beyond 24 h of birth in transgenic and non transgenic Dhcr7-/pups
###end p 32
###begin p 33
###xml 2 5 2 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg </italic>
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT </italic>
###xml 55 64 55 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7+/- </italic>
* Tg positive and negative pups are included in WT and Dhcr7+/- groups. **Survival is defined as being alive beyond 24 hours after being born.
###end p 33
###begin title 34
Association of cholesterol and 7/8DHC with lipid membranes
###end title 34
###begin p 35
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 476 483 476 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, Dhcr7</italic>
###xml 483 486 483 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 486 490 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 499 502 499 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 502 506 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B&#8211;D</xref>
###xml 912 914 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 969 971 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 1170 1172 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 1251 1253 1251 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1254 1256 1254 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1262 1267 1262 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1267 1270 1267 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1270 1274 1270 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 1453 1455 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 1460 1462 1460 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 1484 1489 1484 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1489 1492 1489 1492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1492 1496 1492 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 1645 1647 1645 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 1652 1654 1652 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 1700 1702 1700 1702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 1873 1875 1873 1875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9E</xref>
###xml 1880 1882 1880 1882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9F</xref>
###xml 1982 1987 1982 1987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1987 1990 1987 1990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1990 1994 1990 1994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 2013 2018 2013 2018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 2018 2021 2018 2021 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2021 2025 2021 2025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 2061 2066 2061 2066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 2066 2069 2066 2069 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2069 2073 2069 2073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 2223 2228 2223 2228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 2228 2231 2228 2231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2231 2235 2231 2235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 2297 2302 2297 2302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 2302 2305 2302 2305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2305 2309 2305 2309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 2401 2406 2401 2406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 2406 2409 2406 2409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2409 2413 2409 2413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 2432 2437 2432 2437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 2437 2440 2437 2440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2440 2444 2440 2444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
Participation in the formation and function of membrane lipid microdomains (rafts) is an important function of cholesterol [20,21]. To address whether the transgene expression led to alterations of sterol distributions between raft and non-raft membrane fractions, we fractionated membranes from lung tissues from these three genotypes. To isolate detergent-resistant membranes (DRMs or rafts), Triton X-100 (TX) extracted postnuclear supernatants prepared from wild-type (WT), Dhcr7-/-Tg- and Dhcr7-/-Tg+ neonatal lungs were differentially fractionated in discontinuous sucrose gradients [22] and analyzed. Figure 9A showed protein and organic-phosphate distribution in TX sucrose gradients; there were no differences between any of the genotypes. Cholesterol and precursor sterols were analyzed from gradient fractions by GC-MS (Fig. 9B-D). In WT lungs, cholesterol was detected as the only major sterol (Fig. 9B, open circles), 7/8DHC levels were undetectable (Fig. 9C, open circles), and showed a bimodal profile, with one sharp peak corresponding to the raft fractions (fractions 2-4), the second peak found in high-density non-raft fractions (fractions 8~11, Fig. 9B), in keeping with previous reports using detergent or detergent-free methods [23-26]. In Dhcr7-/-Tg- lungs, sterols composed of a mixture of 7/8DHC and cholesterol, also exhibited bimodal profiles, and 7/8DHC constituted the major sterol in both raft and non-raft fractions (Fig. 9B and 9C, filled circles). In Dhcr7-/-Tg+ lungs, although, in both raft and non-raft fractions, cholesterol was dramatically increased, considerable amount of 7/8DHC was still detected (Fig. 9B and 9C, filled diamonds). Total sterol levels (Fig. 9D) were similar in all three groups. Quantitative analyses of sterol content in rafts (n = 3, pooled fractions 2~4) and non-rafts (pooled fractions 8~11) are shown in Fig. 9E and 9F, respectively. Significantly increased cholesterol, ~70 % of WT levels, was observed in rafts from Dhcr7-/-Tg+ lungs, compared to Dhcr7-/-Tg- lungs. However, raft cholesterol in Dhcr7-/-Tg+ lung was still significantly lower than that in WT lungs. Raft 7/8DHC level was significantly reduced, but a considerable accumulation was evident in Dhcr7-/-Tg+ lungs. Interestingly, although non-raft cholesterol levels in Dhcr7-/-Tg+ lungs were comparable to WT, there was no significant decrease of non-raft 7/8DHC levels in Dhcr7-/-Tg+ lungs, compared to Dhcr7-/-Tg- lungs. These data suggest that precursor sterols can be found in raft fractions, but that total sterol distributions appear to be similar in WT and knockout lungs.
###end p 35
###begin p 36
###xml 0 112 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Characterization of sterol distributions in lipid membranes in wild-type, knockout and knockout-transgenic lungs</bold>
###xml 236 243 236 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">, Dhcr7</italic>
###xml 243 246 243 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 276 279 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 279 281 279 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 949 958 949 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT, Dhcr7</italic>
###xml 958 961 958 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 961 965 961 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg- </italic>
###xml 969 974 969 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 974 977 974 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 977 979 977 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
Characterization of sterol distributions in lipid membranes in wild-type, knockout and knockout-transgenic lungs. Panel A shows the distributions of protein and phosphate in membrane fractions from sucrose gradients of WT (open circles), Dhcr7-/-Tg- (closed circles) and Dhcr7-/-Tg+ (filled diamonds) lungs. Fractions 2-4 represent buoyant fractions indicative of rafts. Panel B shows the distribution of cholesterol, Panel C that for precursor sterols 7/8DHC and Panel D that for total sterol (symbols as above). While the total sterol profiles are indistinguishable (Panel D), precursor sterols are increased and cholesterol decreased in the lungs from knockout animals (Panels B and C). Note that the distribution of precursor sterols is also bimodal in knockout lungs and the improvement of the cholesterol/precursor ratio by the Tg status. Quantitative comparison of sterol composition in rafts (fraction 2~4) and non-rafts (fractions 8~11) in WT, Dhcr7-/-Tg- and Dhcr7-/-Tg+ lungs was performed on three separate samples and data were normalized to organic-phosphate, Panel E and F. Results are expressed as mean +/- SD. Genotypes are as indicated. See Results for discussion.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 77 83 77 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7 </italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Severe cholesterol deficiency, caused by the intentional genetic ablation of Dhcr7 in the mouse, has proven to be incompatible with perinatal life and is associated with respiratory insufficiency after birth [12-14]. However, Dhcr7 null pups also exhibit other defects that indicate other organs/systems are also disrupted by absence of normal cholesterol synthesis. A key question is therefore which of these organs (whose lack of normal development) leads to the neonatal lethality. The hypoxia and abnormal lung phenotype would suggest this could be a major defect, though it is also possible that a failure to integrate respiration at the CNS level could be equally important. In our preliminary effort to restore DHCR7 activity in the CNS, we reported a stochastic rescue of pups up to 3 weeks beyond birth, despite almost no increase in brain cholesterol, or fall in precursor sterol concentrations [15]. At the same time, we had also embarked upon restoration of cholesterol synthesis in peripheral (non-brain) tissues to see if this could abrogate the lethality. We report herein the effects of restoration of cholesterol synthesis in the developing liver, an organ that can circulate lipoproteins and cholesterol at a very embryonic age.
###end p 38
###begin p 39
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
Selective reconstitution of liver cholesterol biosynthesis resulted in significant improvement of cholesterol homeostasis in all of the tissues examined in Dhcr7 null mice with the exception of the brain, confirming the embryonic liver's ability to supply cholesterol to peripheral tissues and the inability of cholesterol in the circulation to cross the blood-brain barrier. Cholesterol was detectable in liver and lung of non-transgenic Dhcr7-null term pups at ~40% of normal levels, which represents maternal transfer of this cholesterol and confirmed previous findings [27]. Cholesterol levels in both liver and lungs of transgenic Dhcr7-null term pups increased to ~80% of WT level (and statistically not different from WT levels), indicating robust transgenic liver expression of DHCR7 led to adequate delivery of endogenously synthesized cholesterol to the lungs (presumably via lipoprotein-mediated transfer). The alleviation of the non-brain tissue cholesterol deficit in the transgenic Dhc7-null embryos led to improvement in the lung development, but not complete restoration of normal development.
###end p 39
###begin p 40
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 619 623 619 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1087 1089 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1090 1092 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1244 1249 1244 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1249 1253 1249 1253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1859 1861 1859 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1862 1864 1862 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
Although our data support the conclusion that the lung defects may not be the major reason for the neonatal mortality, some caveats need to be mentioned. Despite significantly increased cholesterol in the lung, the sterol precursors were reduced by ~40% and not completely suppressed. Sterol precursors have been demonstrated to be part of plasma membranes and their presence may have significant implications in altering membrane signaling, by altering raft formation and functions [28-33]. In this study, membrane sterol distributions were further investigated and compared between transgenic and non-transgenic Dhcr7-/- lungs. Adapting an established method, lipid-rafts and non-rafts were prepared by sucrose gradient fractionation of Triton X100 extracted tissue homogenates [22]. Bimodal profiles of cholesterol and 7/8DHC in sucrose gradient fractions were found, with first peak enriched in "raft" fractions and the second peak found in non-raft fractions. Thus, the bimodal profile may represent sterol portions distributed in lipid-raft microdomains and subcellular membranes [23,25]. As expected, although significant restoration of cholesterol level, a considerable amount of 7/8DHC was still accumulated in the rafts of transgenic Dhcr7-/- lungs. Thus one mechanistic possibility is that raft-mediated signaling may be important for the terminal differentiation of Type 1 AECs (and capillary endothelial cells), and that this defect was not fully complemented by increasing the uptake of cholesterol from exogenous sources and thus the lung-associated mortality was not altered. The defect in cholesterol biosynthesis in the lungs will continue to lead to generation of precursor sterols and since these sterols are readily incorporated into plasma membranes, restoration of normal raft function may require direct restoration of Dhcr7 activity [30-34].
###end p 40
###begin p 41
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1191 1193 1191 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1799 1801 1799 1801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
Another possibility is that pulmonary surfactant alteration may also play a role in the Dhcr7-deficient lung phenotype, since pulmonary surfactant, the lipid-protein material that stabilizes the respiratory surface of the lung, has been described to function as lipid microdomains. However, we have reported that expression of surfactant proteins, both at the mRNA and at the immunohistochemical level, was indistinguishable between Dhcr7-null and wild-type embryos [14]. Cholesterol concentration, a critical parameter in modulating the lateral structure of pulmonary surfactant membranes as evidenced by in-vitro studies, may provide a structural scaffold for surfactant proteins to act at appropriate local densities and lipid composition [35]. A difference in the condensing ability of cholesterol and 7DHC in monolayer films of dipalmitoyl phosphatidylcholine (DPPC), a major surfactant phospholipid, and their different abilities to form lateral domains with DPPC has also been demonstrated [36]. Sterols can induce upregulation of phosphatidylcholine synthesis in cultured fibroblasts and this process is affected by the double-bond position in the sterol tetracyclic ring structure [37]. Therefore, markedly reduced cholesterol content and the massive accumulation of precursor sterols, such as 7/8DHC, may affect lung developmental at late gestational stages by the modulation of surfactant properties, even if surfactant protein expression is normal. However, restoration of DHCR7 activity in the lung using a transgene that expressed DHCR7 activity did not rescue this lethality (Yu and Patel, unpublished observations). Additionally, our previous brain-specific DHCR7 transgenic expression studies showed that some rescue was possible, even though lung sterol profiles were not altered [15]. Thus, while lung defects remain a contributory factor for this lethality, we contend that a defect in the CNS is the major reason why SLOS pups die soon after birth.
###end p 41
###begin p 42
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 601 606 <span type="species:ncbi:10090">mouse</span>
Some positive aspects should also be highlighted. Since the only cells that could synthesize cholesterol were the hepatocytes in the developing liver, yet there was robust restoration of cholesterol in the peripheral organs, this further confirms previous studies on the importance of lipoprotein-mediated liver-derived cholesterol delivery to these organs [18]. Additionally, this study also confirms the now well-established physiological observation that the blood-brain barrier is an absolute barrier for entry of pre-formed cholesterol into the brain and it is operational as early as E10 in the mouse [27].
###end p 42
###begin p 43
###xml 371 376 <span type="species:ncbi:10090">mouse</span>
One curious finding confounding the above interpretations is that, although cholesterol levels in the transgenic Dhcr7-null livers increased to almost WT levels, the precursor levels in the liver were reduced by only 70 %, despite an almost 5-fold increase in the relative expression of the transgene in the liver. Our explanation for this is that the fetal and neonatal mouse liver contains more than hepatocytes, with a significant amount of hematopoetic activity that persists beyond birth. The ApoE promoter chosen will only result in robust hepatic-specific expression. Since total dissected organ tissue sterols are measured, we presume that the precursor accumulations are therefore primarily in these non-hepatic cells and not hepatocytes. If so, it also suggests that close proximity of the hepatocytes and hematopoetic stem cells does not result in complementation or clearance of the precursor sterols from the latter. Thus, while cholesterol can be efficiently delivered to the various tissues readily via the lipoprotein-mediated pathways, removal of the precursor sterols back to the liver may not be as efficient.
###end p 43
###begin title 44
Conclusion
###end title 44
###begin p 45
Restoration of liver cholesterol synthesis is an efficient method to restore peripheral tissue cholesterol in Dhcr7-null embryos, and this can lead to an improvement in the lung developmental defects reported previously and a minimal improvement in the neonatal lethality was also observed. However, this strategy does not affect the sterol defect in the CNS and this organ may be critically responsible for the neonatal lethality.
###end p 45
###begin title 46
Methods
###end title 46
###begin title 47
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
###xml 41 46 <span type="species:ncbi:9606">human</span>
Generation of transgenic mice expressing human DHCR7specifically in liver
###end title 47
###begin p 48
###xml 531 535 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlu </italic>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla </italic>
###xml 571 575 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not </italic>
###xml 577 581 577 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spe </italic>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 994 1001 994 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7</italic>
###xml 1228 1232 1227 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam </italic>
###xml 1350 1352 1349 1351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1774 1784 1773 1783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7-2 </italic>
###xml 1788 1797 1787 1796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7-3</italic>
###xml 1931 1936 1930 1935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 1936 1940 1935 1939 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1998 2000 1997 1999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 2001 2003 2000 2002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 2024 2032 2023 2031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 2050 2055 2049 2054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 2055 2059 2054 2058 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 2059 2063 2058 2062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 2119 2124 2118 2123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 2124 2127 2123 2126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2127 2131 2126 2130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg+ </italic>
###xml 12 27 <span type="species:ncbi:10090">transgenic mice</span>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 293 298 <span type="species:ncbi:9606">human</span>
###xml 514 519 <span type="species:ncbi:9606">human</span>
###xml 705 720 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1003 1007 <span type="species:ncbi:10090">mice</span>
###xml 1128 1132 <span type="species:ncbi:10090">mice</span>
###xml 1369 1374 <span type="species:ncbi:9606">human</span>
###xml 1412 1417 <span type="species:ncbi:9606">human</span>
###xml 1553 1557 <span type="species:ncbi:10090">mice</span>
###xml 1650 1654 <span type="species:ncbi:10090">Mice</span>
###xml 1731 1735 <span type="species:ncbi:10090">mice</span>
###xml 1940 1944 <span type="species:ncbi:10090">mice</span>
###xml 2131 2135 <span type="species:ncbi:10090">mice</span>
###xml 2141 2156 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2214 2218 <span type="species:ncbi:10090">mice</span>
###xml 2247 2251 <span type="species:ncbi:10090">mice</span>
###xml 2335 2340 <span type="species:ncbi:10090">Mouse</span>
###xml 2341 2344 <span type="species:ncbi:10116">Rat</span>
###xml 2478 2493 <span type="species:ncbi:10090">transgenic mice</span>
To generate transgenic mice expressing DHCR7 in the liver, we used a pLIV-LE6 vector that contains the constitutive human Apo E gene promoter and its hepatic control region (a gift from John Taylor, J. David Gladstone Institutes, San Francisco). N-terminal 3 hemagglutinin (HA) epitope tagged human DHCR7 cDNA with intron 5 (3HA-DHCR7in5) was generated by routine PCR insertion method. The transgenic plasmid (pLiv-11-3HA-DHCR7in5) was generated by cloning 3HA-DHCR7in5 fragment encoding the open reading frame of human DHCR7 into Mlu I-Cla I sites of pLIV-LE6. The 6-kb Not I-Spe I fragment of pLiv-11-3HA-DHCR7in5 (Fig. 1) was then isolated and injected into fertilized eggs (C57Bl x FVB/N) to generate transgenic mice by Medical University of South Carolina Transgenic Core facility. Transgene-specific PCR with the forward primer 5'-ATGGAGAGGAGGGGGCTGAGA-3' and the reverse primer 5'-TGGATTTTGCCAATAATGTCCAGC-3' was used for routine genotyping for transgene status. Tail DNA of transgenic (TgDHCR7) mice produced a PCR product of 530 bp (data not shown). Southern blots of tail DNAs were performed to identify three founder mice that harbored the integrated transgene. For Southern analysis, 10 mug of DNA was digested with Bam HI. The digested DNA was separated on a 0.8% agarose gel, transferred to a Hybond-N membrane, and hybridized with the 32P-labeled 1.5 kb human DHCR7 cDNA. Expression levels of the human DHCR7 transgene were determined by RT-PCR and Western blot analyses, on tissues of offspring from positive founders bred with C57BL/6J mice. Quantitative analyses of transgene expression were performed by real-time PCR (see below). Mice with high levels of transgene expression in the liver were bred to C57BL/6J mice, and two integrated transgenic lines, TgDHCR7-2 and TgDHCR7-3, were established. Both lines showed almost identical patterns of transgene expression and were used interchangeably in all crosses. Dhcr7+/- mice (N>12 on C57Bl/6J background), described previously [14,27], were crossed with TgDHCR7 lines to generate Dhcr7+/- Tg+ animals. These were subsequently intercrossed to obtain Dhcr7-/-Tg+ mice. The transgenic mice were maintained as hemizygotes by breeding with C57BL/6J mice (Jackson Laboratories). All mice were housed in colony cages with a 12-hour light/12-hour dark cycle and fed Teklad Mouse/Rat Diet 7002 from Harlan Teklad (Madison, Wisconsin, USA). For animal experiments, non-transgenic littermates were used as controls for transgenic mice. All animal experiments were performed with the approval of the Institutional Animal Care and Research Advisory Committee at Medical College of Wisconsin.
###end p 48
###begin title 49
Tissue expression of TgDHCR7
###end title 49
###begin p 50
###xml 131 139 131 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 397 405 396 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 597 603 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7 </italic>
###xml 757 759 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 996 1004 959 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 1206 1208 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1657 1665 1617 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TgDHCR7 </italic>
###xml 425 430 <span type="species:ncbi:9606">human</span>
###xml 548 554 <span type="species:ncbi:10090">murine</span>
###xml 1332 1337 <span type="species:ncbi:9606">human</span>
###xml 1437 1443 <span type="species:ncbi:10090">murine</span>
###xml 1731 1737 <span type="species:ncbi:10090">murine</span>
Total RNA was extracted from multiple tissues from postnatal 10-day-old offspring or livers of embryos at E11.5, E13.5, E16.5 from TgDHCR7 lines, as described previously [14,15]. Random hexamers were used as primers for reverse transcription of 1 mug of total RNA, and cDNA first-strand synthesis carried out using Thermoscript (Invitrogen) according to manufacturer's protocol. Specific mRNA for TgDHCR7 was amplified using human DHCR7 cDNA primers (forward: 5'-GGACTGGTTTTCACTGGCGAGCG-3' and reverse: 5'-CCAGAGCAGGTGCGTGAGGAG-3'). The endogenous murine Dhcr7 and beta-actin were amplified using Dhcr7 cDNA primers (forward: 5'-CCAAAGTCAAGAGTCCCAACGG-3' and reverse: 5'-ACCAGAGGATGTGGGTAATGAGC-3') and the beta-actin gene primers, as described previously [15]. PCR amplification was carried out as follows: denaturation for 3 min at 94degreesC and then a succession of 30 cycles by 30 sec at 94degreesC, 30 sec at 58degreesC, 1 min at 72degreesC, and a final extension at 72degreesC for 10 min. TgDHCR7 RT-PCR products (350 bp) were gel-purified and sequenced to confirm it contained correct spliced products using an automated capillary sequencer (Beckman Coulter CEQ 8000, CA), as previously described [15]. SYBR-Green real-time PCR quantification of transgene transcripts was performed with ABI 7300 Real-time PCR system, using human DHCR7 cDNA primers (forward: 5'-CCCAGCTCTATACCTTGTGG-3' and reverse: 5'-CCAGAGCAGGTGCGTGAGGAG-3'), murine Dhcr7 cDNA primers (forward: GCCAAGACACCACCTGTGACAG-3' and reverse: 5'-TGGACGCCTCCCACATAACC-3') and beta-actin primers (forward: ACCCTGTGCTGCTCACCGAG-3'and reverse: 5'-TGCCTGTGGTACGACCAGAGG-3'). Quantification of TgDHCR7 mRNA levels in transgenic livers on E16.5, relative to endogenous murine Dhcr7 mRNA, was performed using quantitative real-time PCR (qRT-PCR), with normalization performed to the beta-actin mRNA abundance from the same sample.
###end p 50
###begin p 51
For immunoblotting analysis of TgDHCR7, tissue membrane fractions were extracted using ProteinExtract native membrane protein extraction kit (Calbiochem, San Diego, CA) according to manufacturer's protocol. Briefly, approximately 50 mg of frozen tissues from brain, lung, liver, spleen, kidney, or skeletal muscle was homogenized in 2 ml of ice cold homogenate buffer added with cocktail of protease inhibitors, using a tissue homogenizer (PRO Scientific Inc., Oxford, CT) by three pulses of 10 seconds each and then subjected to Dounce homogenizer, pestle A, by 20 strokes. The homogenates were centrifuged at 16,000 g for 15 minutes at 4degreesC and supernatants referred as to cytosolic fractions. The pellets were resuspended in lysis buffer and gentled shaken for 30 minutes at 4degreesC, followed by centrifugation at 16,000 g for 15 minutes at 4degreesC. The supernatants were collected and referred as to membrane fractions. Protein concentrations in each cytosolic and membrane fractions were determined using Bio-Rad protein assay kit (Bio-Rad, Hercules, CA) and 40 mug of protein from each sample was separated by 8% SDS-PAGE, transferred onto nitrocellulose membranes, incubated with HA monoclonal antibody (1:400, Santa Cruz Biotechnology, Santa Cruz, CA), Calnexin polyclonal antibody (1:200, Santa Cruz Biotechnology), or caveolin-1 (1:400, Santa Cruz Biotechnology) for 2 hours, followed by HRP second antibodies (1:4000, Santa Cruz Biotechnology), and visualized by chemiluminescent detection according to manufacturer's protocols (Perkin-Elmer Life Sciences, Boston, MA).
###end p 51
###begin title 52
Biochemical analyses
###end title 52
###begin p 53
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
Sterol composition in tissues and plasma (pooled plasma collected by decapitation from 9 animals, pooling performed by combining plasma from 3 pups) were identified and quantitated by gas-chromatography-mass spectrometry (GC-MS) as described previously [3].
###end p 53
###begin title 54
Histology and immunohistochemistry
###end title 54
###begin p 55
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 249 253 249 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(WT)</italic>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 264 268 264 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 268 270 268 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dhcr7</italic>
###xml 281 285 281 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 285 287 285 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg</italic>
###xml 582 584 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
Timed pregnant females at embryonic day (E) 19.5 were sacrificed. E19.5 fetuses were dissected free from the uteri and thoracic body parts harvested, fixed in 10% neutral buffered formalin, and embedded in paraffin. Tissues from non-transgenic Dhcr7+/+ (WT), Dhcr7-/- Tg- and Dhcr7-/- Tg+ animals were cut into 5-mum sections and stained with hematoxylin-eosin for routine histological examination. Immunohistochemistry (IHC) to determine T1-alpha, SP-C, caveolin-1 (cav-1) and PECAM-1 expression in tissue sections was performed in standard IHC procedures as described previously [14]. Immunofluorescence staining was performed to determine TgDHCR7 expression in livers by use of a monoclonal anti-HA probe conjugated with TRITC (1:200, Santa Cruz Biotechnology).
###end p 55
###begin title 56
Isolation of detergent-resistant lipid rafts
###end title 56
###begin p 57
###xml 50 52 50 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 258 259 258 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 292 293 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 295 296 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 444 446 439 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 1274 1276 1263 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
A modification of the method of Mukherjee et al. [22] was used to isolate lipid rafts from neonatal lung tissues. Briefly, frozen lung tissues were homogenized in an ice-cold lysis buffer containing 5% glycerol in buffer A (50 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 0.15 M NaCl, 20 mM NaF, 1 mM Na3VO4, 5 mM beta-mercaptoethanol, 10 mug/ml aprotinin, 10 mug/ml leupeptin, 1 mM PMSF). Tissue debris and nuclei were removed by centrifugation at 1,000 g for 5 minutes. Protein concentration of the postnuclear supernatants (PNS) was measured using Protein Reagent (Bio-Rad) and adjusted to 2 mg/ml. 10 % Triton X-100 (TX) was added to 2 ml of PNS to a final concentration of 0.5 % TX followed by a 30 min incubation on ice. The samples were mixed with equal volume of 80 % (w/v) sucrose in buffer A, and then overlaid with 2.0 ml each of 35, 30, 25, and 5 % (w/v) sucrose (all in buffer A). Sucrose gradient was spun at 38,000 rpm in a Sorval 90 ultracentrifuge using TH-641 rotor for 15 hr at 4degreesC. Twelve fractions of each 1.0 ml were collected from the top to bottom. Sterol composition in each 12 fractions and pooled lipid-raft and non-raft fractions was quantitatively determined as described above and normalized to organic-phosphate as determined by a phosphate assay [38]. Based on cholesterol profile, as well as cellular organelle protein markers and sphingolipid profile (data not shown), lipid rafts or detergent resistant membranes (DRMs) were defined as the membrane materials that floated at the interface of 5% and 25% sucrose in the density range 1.055~1.115 g/ml (fraction 2~4); non-raft materials were collected in the density range 1.130~1.180 g/ml (fraction 8~11).
###end p 57
###begin title 58
Authors' contributions
###end title 58
###begin p 59
HY and SBP conceived of the study and designed the experiments. HY, ML, GRX and JLC carried out the experiments. HY. GST and SBP analyzed the data and prepared the manuscript. All authors read and approved the final manuscript.
###end p 59
###begin title 60
Acknowledgements
###end title 60
###begin p 61
###xml 62 67 <span type="species:ncbi:9606">human</span>
The authors would like to thank Dr. John Taylor for providing human apoE gene promoter plasmid, to Abigail Maciolek, Yanhong Cai and Bibi Pcolinsky for technical assistance. This research was supported by a Biomedical Research Grant RG-11311-M from the American Lung Association (HY), by grants from the Office of Research and Development, Department of Veterans Affairs (GST and GX); and by PHS grant HL68660 from the National Heart, Blood and Lung Institute, NIH (SBP).
###end p 61
###begin article-title 62
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human malformation syndromes due to inborn errors of cholesterol synthesis
###end article-title 62
###begin article-title 63
Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes
###end article-title 63
###begin article-title 64
Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome
###end article-title 64
###begin article-title 65
Cholesterol and development: the RSH ("Smith-Lemli-Opitz") syndrome and related conditions
###end article-title 65
###begin article-title 66
The Smith-Lemli-Opitz syndrome
###end article-title 66
###begin article-title 67
Recent insights into the Smith-Lemli-Opitz syndrome
###end article-title 67
###begin article-title 68
Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis
###end article-title 68
###begin article-title 69
Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay
###end article-title 69
###begin article-title 70
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome
###end article-title 70
###begin article-title 71
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome
###end article-title 71
###begin article-title 72
Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene
###end article-title 72
###begin article-title 73
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome
###end article-title 73
###begin article-title 74
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith--Lemli--Opitz syndrome
###end article-title 74
###begin article-title 75
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Late gestational lung hypoplasia in a mouse model of the Smith-Lemli-Opitz syndrome
###end article-title 75
###begin article-title 76
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Partial rescue of neonatal lethality of Dhcr7 null mice by a nestin promoter-driven DHCR7 transgene expression
###end article-title 76
###begin article-title 77
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover
###end article-title 77
###begin article-title 78
###xml 85 88 <span type="species:ncbi:10116">rat</span>
Cholesterol synthesis and accretion within various tissues of the fetal and neonatal rat
###end article-title 78
###begin article-title 79
###xml 49 52 <span type="species:ncbi:10116">rat</span>
Sources of cholesterol during development of the rat fetus and fetal organs
###end article-title 79
###begin article-title 80
###xml 104 109 <span type="species:ncbi:9940">sheep</span>
Brain does not utilize low density lipoprotein-cholesterol during fetal and neonatal development in the sheep
###end article-title 80
###begin article-title 81
Cholesterol, lipid rafts, and disease
###end article-title 81
###begin article-title 82
Model systems, lipid rafts, and cell membranes
###end article-title 82
###begin article-title 83
Lipid-dependent recruitment of neuronal Src to lipid rafts in the brain
###end article-title 83
###begin article-title 84
Biochemical characterization of detergent-resistant membranes: a systematic approach
###end article-title 84
###begin article-title 85
Domain-specific lipid distribution in macrophage plasma membranes
###end article-title 85
###begin article-title 86
###xml 76 98 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
A stomatin and a degenerin interact in lipid rafts of the nervous system of Caenorhabditis elegans
###end article-title 86
###begin article-title 87
Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles
###end article-title 87
###begin article-title 88
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols
###end article-title 88
###begin article-title 89
7-Dehydrocholesterol enhances ultraviolet A-induced oxidative stress in keratinocytes: roles of NADPH oxidase, mitochondria, and lipid rafts
###end article-title 89
###begin article-title 90
A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome
###end article-title 90
###begin article-title 91
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness
###end article-title 91
###begin article-title 92
Steroid structural requirements for interaction of ostreolysin, a lipid-raft binding cytolysin, with lipid monolayers and bilayers
###end article-title 92
###begin article-title 93
Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome
###end article-title 93
###begin article-title 94
Cholesterol precursors stabilize ordinary and ceramide-rich ordered lipid domains (lipid rafts) to different degrees. Implications for the Bloch hypothesis and sterol biosynthesis disorders
###end article-title 94
###begin article-title 95
Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebrosides, and ceramide
###end article-title 95
###begin article-title 96
Cholesterol rules: direct observation of the coexistence of two fluid phases in native pulmonary surfactant membranes at physiological temperatures
###end article-title 96
###begin article-title 97
A comparison of the behavior of cholesterol and selected derivatives in mixed sterol-phospholipid Langmuir monolayers: a fluorescence microscopy study
###end article-title 97
###begin article-title 98
Sterol-induced upregulation of phosphatidylcholine synthesis in cultured fibroblasts is affected by the double-bond position in the sterol tetracyclic ring structure
###end article-title 98
###begin article-title 99
Inorganic and organic phosphate measurements in the nanomolar range
###end article-title 99

